Abstract
Somatoform disorders are among the most prevalent psychiatric disorders in general practice. A somatoform disorder was diagnosed in 16.1 % of consecutive consulting patients [1]. Patients with somatoform disorders are often referred to as “medical orphans” [2], because correct diagnosis is not made by physicians and the patients end up “shopping” for diagnoses by visiting many physicians.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
De Waal, M. W., Arnold, I. A., Eekhof, J. A., et al. (2004). Somatoform disorders in general practice: Prevalence, functional impairment and comorbidity with anxiety and depressive disorders. The British Journal of Psychiatry, 184, 470–476.
Aronowitz, R. A. (2001). When do symptoms become a disease? Annals of Internal Medicine, 134, 803–808.
Dimsdale, J. E., & Dantzer, R. (2007). A biological substrate for somatoform disorders: Importance of pathophysiology. Psychosomatic Medicine, 69, 850–854.
Rief, W., & Rojas, G. (2007). Stability of somatoform symptoms – implications for classification. Psychosomatic Medicine, 69, 864–869.
Mayou, R., Kirmayer, L. J., Simon, G., et al. (2005). Somatoform disorders: Time for a new approach in DSM-V. The American Journal of Psychiatry, 162, 847–855.
Bass, C. M., & Murphy, M. R. (1990). Somatization disorder: Critique of the concept and suggestions for further research. In C. M. Bass & R. H. Cawley (Eds.), Somatization: Physical symptoms and psychological illness. Oxford, UK: Blackwell Scientific.
Rost, K. M., Atkins, R. M., Brown, F. W., et al. (2003). The comorbidity of DSM-III-R personality disorders in somatization disorder. General Hospital Psychiatry, 14, 322–326.
Simon, G. E., & Gureje, O. (1999). Stability of somatization disorder and somatization symptoms among primary care patients. Archives of General Psychiatry, 56, 90–95.
Katon, W., Lin, E., Von Korff, M., et al. (1991). Somatization: A spectrum of severity. The American Journal of Psychiatry, 148, 34–40.
Barsky, A. J., Wyshak, G., & Klerman, G. L. (2003). Hypochondriasis: An evaluation of the DSM-III criteria in medical outpatients. Archives of General Psychiatry, 43, 493–500.
Salkovskis, P. M., & Warwick, H. M. (1986). Morbid preoccupation, health anxiety and reassurance: A cognitive-behavioral approach to hypochondriasis. Behaviour Research and Therapy, 24, 597–602.
Hyler, S. E., & Spitzer, R. L. (1978). Hysteria split asunder. The American Journal of Psychiatry, 135, 1500–1504.
Martin, R. L. (1992). Diagnostic issues for conversion disorder. Hospital & Community Psychiatry, 43, 771–773.
Chang, D. F., Myers, H. F., Yeung, A., et al. (2005). Shenjing shuairuo and the DSM-IV: Diagnosis, distress, and disability in a Chinese primary care setting. Transcultural Psychiatry, 42, 204–218.
LeiKeiknes, K. A., Finset, A., Mount, T., et al. (2007). Current somatoform disorders in Norway: Prevalence, risk factors and comorbidity with anxiety, depression and musculoskeletal disorders. Social Psychiatry and Psychiatric Epidemiology, 42, 698–710.
Sullivan, M. D. (2000). DSM-IV pain disorder: A case against the diagnosis. International Review of Psychiatry, 12, 91–98.
Phillips, K. A., McElroy, S. L., Hudson, J. I., et al. (1995). Body dysmorphic disorder: An obsessive-compulsive spectrum disorder, a form of affective spectrum disorder, or both? The Journal of Clinical Psychiatry, 56(suppl. 4), 41–51.
Lowe, B., Mundt, M., Herzog, W., et al. (2008). Validity of current somatoform disorder diagnoses: Perspectives for classification in DSM-V and ICD-11. Psychopathology, 41, 4–9.
Kroenke, K., Sharpe, M., Sykes, R., et al. (2007). Revising the classification of somatoform disorders: Key questions and preliminary recommendations. Psychosomatics, 48, 277–285.
Janka, A. (2005). Rethinking somatoform disorders. Current Opinion in Psychiatry, 18, 65–71.
Creed, F. (2006). Can DSM-V facilitate productive research into the somatoform disorders? Journal of Psychosomatic Research, 60, 331–334.
Smith, R., Gardiner, J., Lyles, J., et al. (2005). Exploration of DSM-IV criteria in primary care patients with medically unexplained symptoms. Psychosomatic Medicine, 67, 123–129.
Hanel, G., Henningsen, P., Herzog, W., et al. (2009). Depression, anxiety, and somatoform disorders: Vague or distinct categories in primary care? Results from a large cross-sectional study. Journal of Psychosomatic Research, 67, 189–197.
Duddu, V., Isaac, M. K., Chaturvedi, S. K., et al. (2006). Somatization, somatosensory amplification, attribution styles and illness behavior: A review. International Review of Psychiatry, 18, 25–33.
Koh, K. B., & Ki, S. W. (1997). A comparison of illness behavior among patients with somatoform disorders, depressive disorders and psychosomatic disorders. Korean Journal of Psychosomatic Medicine, 5, 185–194.
Rief, W., Hiller, W., & Margraf, J. (1998). Cognitive aspects of hypochondriasis and the somatization syndrome. Journal of Abnormal Psychology, 107, 587–595.
Aggarwal, V. R., McBeth, J., Zakrzewska, J. M., et al. (2006). The epidemiology of chronic syndromes that are frequently unexplained: Do they have common associated factors? [see comment]. International Journal of Epidemiology, 35, 468–476.
Noyes, R., Stuart, S., Watson, D. B., et al. (2006). Distinguishing between hypochondriasis and somatization disorder: A review of the existing literature. Psychotherapy and Psychosomatics, 75, 270–281.
Koh, K. B., Kim, C. H., & Park, J. K. (2002). Predominance of anger in depressive disorder compared to anxiety disorder and somatoform disorder. The Journal of Clinical Psychiatry, 63, 486–492.
Koh, K. B., Kim, D. K., Kim, S. Y., et al. (2008). The relation between anger management style, mood, and somatic symptoms in anxiety disorders and somatoform disorders. Psychiatry Research, 160, 372–379.
Koh, K. B., Kim, D. K., Kim, S. Y., et al. (2005). The relation between anger expression, depression, and somatic symptoms in depressive disorders and somatoform disorders. The Journal of Clinical Psychiatry, 66, 485–491.
Shipko, S. (1982). Alexithymia and somatization. Psychotherapy and Psychosomatics, 37, 193–201.
Burba, B., Oswald, R., Grigaliunien, V., et al. (2006). A controlled study of alexithymia in adolescent patients with persistent somatoform pain disorder. Canadian Journal of Psychiatry, 51, 468–471.
Nunez, G., Rufer, M., Leenen, K., et al. (2010). Quality of life and alexithymia in somatoform pain disorder. Schmerz, 24, 62–68.
Koh, K. B. (1994). Comparison of alexithymia among patients with psychosomatic disorders, anxiety disorders and depressive disorders. Korean Journal of Psychosomatic Medicine, 2, 59–68.
Rief, W., & Broadbent, E. (2007). Explaining medically unexplained symptoms-models and mechanisms. Clinical Psychology Review, 27, 821–841.
Kolk, A. M., Schagen, S., & Hanewald, G. J. (2004). Multiple medically unexplained physical symptoms and health care utilization: Outcome of psychological intervention and patient-related predictors of change. Journal of Psychosomatic Research, 57, 379–389.
Rief, W., Martin, A., Klaiberg, A., et al. (2005). Specific effects of depression, panic, and somatic symptoms on illness behavior. Psychosomatic Medicine, 67, 596–601.
Guggenheim, F. G. (2000). Somatoform disorder. In B. J. Sadock & V. A. Sadock (Eds.), Comprehensive textbook of psychiatry (7th ed.). Baltimore, MD: Lippincott Williams & Wilkins.
Koh, K. B. (2002). Stress and psychosomatic medicine (pp. 231–249). Seoul, Korea: Ilchokak.
Mezzich, J. E., Lin, K., & Hughes, C. C. (2000). Acute and transient psychotic disorders and culture bound syndromes. In B. J. Sadock & V. A. Sadock (Eds.), Comprehensive textbook of psychiatry (7th ed., pp. 1264–1276). Baltimore, MD: Lippincott Williams & Wilkins.
Lin, K. M. (1983). Hwa-byung: A Korean culture-bound syndrome? The American Journal of Psychiatry, 140, 105–107.
Min, S. K. (1989). A study of the concept of hwabyung. Journal of Korean Neuropsychiatric Association, 28, 604–616.
Lee, S., & Kleinman, A. (2007). Are somatoform disorders changing with time? The case of neurasthenia in China. Psychosomatic Medicine, 69, 846–849.
Leiknes, K. A., Finset, A., & Moum, T. (2010). Commonalities and differences between the diagnostic groups: Current somatoform disorders, anxiety and/or depression, and musculoskeletal disorders. Journal of Psychosomatic Research, 68, 439–446.
Nutt, D. J., & Stein, D. J. (2006). Understanding the neurobiology of comorbidity in anxiety disorders. CNS Spectrums, 11, 13–20.
Koh, K. B., Kang, J. I., Lee, J. D., et al. (2010). Shared neural activity in panic disorder and undifferentiated somatoform disorder compared with healthy controls. The Journal of Clinical Psychiatry, 71, 1576–1581.
Valet, M., Gundel, H., Sprenger, T., et al. (2009). Patients with pain disorder show gray-matter loss in pain-processing structures: A voxel-based morphometric study. Psychosomatic Medicine, 71, 49–56.
Uchida, R. R., Del-Ben, C. M., Busatto, G. F., et al. (2008). Regional gray matter abnormalities in panic disorder: A voxel-based morphometry study. Psychiatry Research, 163, 21–29.
van Tol, M.-J., van der Wee, N. J. A., van den Heuvel, O. A., et al. (2010). Regional brain volume in depression and anxiety disorders. Archives of General Psychiatry, 67, 1002–1011.
Drevets, W. C. (2001). Neuroimaging and neuropathological studies of depression: Implications for the cognitive-emotional features of mood disorders. Current Opinion in Neurobiology, 11, 240–249.
Koh, K. B., Choi, E. H., Lee, Y., et al. (2011). Serotonin-related gene pathways associated with undifferentiated somatoform disorder. Psychiatry Research, 189, 246–250.
Koh, K. B., Kim, C. H., Choi, E. H., et al. (2012). Effect of tryptophan hydroxylase gene polymorphism on aggression in major depressive disorder and undifferentiated somatoform disorder. The Journal of Clinical Psychiatry, 73, e574–e579.
Zill, P., Baghai, T. C., Zwanzger, P., et al. (2004). SNP and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene provide evidence for association with major depression. Molecular Psychiatry, 9, 1030–1036.
Oquendo, M. A., & Mann, J. J. (2001). Neuroimaging findings in major depression, suicidal behavior and aggression. Clinical Neuroscience Research, 1, 377–380.
Rosenthal, N. E., Mazzanti, C. M., Barnett, R. L., et al. (1998). Role of serotonin transporter promoter repeat length polymorphism (5-HTTLPR) in seasonality and seasonal affective disorder. Molecular Psychiatry, 3, 175–177.
Maron, E., Hettema, J. M., & Shlik, J. (2010). Advances in molecular genetics of panic disorder. Molecular Psychiatry, 15, 681–701.
Koh, K. B., Sohn, S.-H., Kang, J. I., et al. (2012). Relationship between neural activity and immunity in patients with undifferentiated somatoform disorder. Psychiatry Research: Neuroimaging, 202, 252–256.
Schleifer, S. J., Keller, S. E., Scotte, B. J., et al. (1990). Lymphocyte function in panic disorder. Biological Psychiatry, 27(suppl. 9A), 66A.
Surman, O. S., Williams, J., Sheehan, D. V., et al. (1986). Immunological response to stress in agoraphobia and panic attacks. Biological Psychiatry, 21, 768–774.
Brambilla, F., Bellodi, L., Perna, G., et al. (1992). Psychoimmunoendocrine aspects of panic disorder. Neuropsychobiology, 26, 12–22.
Andreoil, A., Keller, S. E., Taban, C., et al. (1990). Immune function in major depressive disorder: Relation to panic disorder comorbidity. Biological Psychiatry, 27(suppl. 9A), 95A.
Koh, K. B., & Lee, B. K. (1998). Reduced lymphocyte proliferation and interleukin-2 production in anxiety disorders. Psychosomatic Medicine, 60, 479–483.
Koh, K. B., & Lee, Y. (2004). Reduced anxiety level by therapeutic interventions and cell-mediated immunity in panic disorder patients. Psychotherapy and Psychosomatics, 73, 286–292.
Marazziti, D., Ambrogi, F., Vanacore, R., et al. (1992). Immune cell imbalance in major depressive and panic disorders. Neuropsychobiology, 26, 23–26.
Irwin, M. R., & Miller, A. H. (2007). Depressive disorders and immunity: 20 years of progress and discovery. Brain, Behavior, and Immunity, 21, 374–383.
Zorrilla, E. P., Luborsky, L., McKay, J. R., et al. (2001). The relationship of depression and stressors to immunological assays: A meta-analytic review. Brain, Behavior, and Immunity, 15, 199–226.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this chapter
Cite this chapter
Koh, K.B. (2013). Identity of Somatoform Disorders: Comparison with Depressive Disorders and Anxiety Disorders. In: Koh, K. (eds) Somatization and Psychosomatic Symptoms. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-7119-6_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-7119-6_1
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-7118-9
Online ISBN: 978-1-4614-7119-6
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)